CurrentBlue Cross Blue Shield - NevadaPolicy N/A

Half-Tablet Prescription Program — Coverage Criteria

Customize your policy alerts

Sign up for all Blue Cross Blue Shield - Nevada policy alerts

Know when Blue Cross Blue Shield - Nevada releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy describing a program that allows prescribing half of certain once-daily oral tablet doses so members pay for fewer tablets; affects commercial medical/pharmacy members eligible for the Half-Tablet benefit (not Medicare or Medicaid).

Policy Summary

PayerBlue Cross Blue Shield - Nevada

PolicyHalf-Tablet Prescription Program — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionWrite prescriptions for qualified once-daily medications with directions to take 1/2 tablet per day and specify the higher-strength tablet and half-tablet directions so pharmacy can dispense half the usual quantity.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

half copaymember savings feature

UniCare commercialpopulation included

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentBlue Cross Blue Shield - NevadaPolicy N/A

Half-Tablet Prescription Program — Coverage Criteria

Customize your policy alerts

Sign up for all Blue Cross Blue Shield - Nevada policy alerts

Know when Blue Cross Blue Shield - Nevada releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerBlue Cross Blue Shield - Nevada

PolicyHalf-Tablet Prescription Program — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

half copaymember savings feature

UniCare commercialpopulation included

Coverage Criteria — Half-Tablet Program

The Half-Tablet benefit excludes medications that are controlled-release, delayed-release, or have a narrow therapeutic index. These formulation characteristics make a tablet inappropriate to split and therefore ineligible for the program.

Provider Actions & Prescribing Guidance

Note

Half‑Tablet prescribing requirement

Write prescriptions for qualified once-daily medications with directions to take 1/2 tablet per day. Specify the equivalent higher-strength tablet on the prescription so the patient fills the stronger product but takes half the tablet daily.

Documentation Required

Patient selection before prescribing

Consider patient and caregiver ability before prescribing a half‑tablet regimen. Screen for limited dexterity, tremor, reduced hand strength, poor vision, or cognitive impairment that could prevent safe splitting or correct dosing. Counsel patients on proper splitting technique and provide a pill splitter when appropriate; avoid half‑tablet prescriptions for patients who cannot reliably split or identify doses.

Billing Rule

How to write the prescription

Prescribe the higher‑strength tablet with directions to take 1/2 tablet once daily and adjust the quantity to reflect the number of whole tablets needed (e.g., to replace Crestor 20 mg daily for 30 days, prescribe Crestor 40 mg — Take 1/2 tablet once daily — Qty = 15). Include clear directions and, when supported by local rules, note ‘split tablet’ on the prescription.

Denial Risk

Ineligible formulations/characteristics

Do not use the Half‑Tablet approach for formulations or products that are inappropriate to split. Ineligible characteristics include controlled‑release, extended‑release, delayed‑release, enteric‑coated formulations, or any product with a narrow therapeutic index where splitting may alter delivery or safety. If the medication is listed as ineligible, prescribe the appropriate strength without splitting.

Initial Prescribing Instructions

Initial prescribing instructions

Formulation restrictions: Do not initiate a half‑tablet prescription for formulations that are controlled‑release, delayed‑release, or have a narrow therapeutic index—these are excluded from the Half‑Tablet benefit.

Selection rules explicitly exclude CR/DR/NTI formulations.

Assessment Before Initiation

Assessment item	Action / counseling
Dexterity and hand strength	Screen patient or caregiver for fine motor ability to split tablets reliably; provide or recommend a pill‑splitter if needed and offer hands‑on demonstration.
Vision	Confirm adequate vision to identify and align tablets for splitting; provide large‑print instructions or caregiver assistance if vision is limited.
Cognitive ability	Assess understanding of dosing schedule and ability to select the correct tablet to split; avoid half‑tablet regimens or arrange caregiver support if cognition is impaired.
Caregiver availability	If the patient cannot manage splitting, confirm a capable caregiver is available and provide counseling on proper splitting and administration.
Provide pharmacist counseling	Recommend pharmacist counseling on tablet splitting, safe storage of halves, and confirming the correct strength and dose when dispensing.

Background

Tablet splitting is used to achieve intermediate doses or reduce cost by prescribing a higher-strength tablet and instructing the patient to take half. The program applies only when there is an expected cost savings, the medication is dosed once a day, and the formulation is appropriate for splitting (not controlled-release, delayed-release, or narrow therapeutic index). Providers should confirm the patient can safely split and manage half-tablet dosing before using this approach.

Definitions & Not Appropriate For Splitting

Controlled‑release, delayed‑release, and narrow therapeutic index formulations — Not appropriate for splitting

Excluded formulationsControlled-release (CR) medications are not appropriate for tablet splitting and are excluded from the Half-Tablet benefit.

Excluded formulationsDelayed-release (DR) medications are not appropriate for tablet splitting and are excluded from the Half-Tablet benefit.

Excluded characteristicsMedications with a narrow therapeutic index (NTI) are not appropriate for tablet splitting and are excluded from the Half-Tablet benefit.